Clinical Trials

New Search
Title   A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)
Disease/Condition   Heart and Vascular Diseases,Cardiology,Geriatrics,Heart Failure
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Jooyoung Julia Shin, MD
Contact Name   Cristal Garcia
Contact Email   crigarci@montefiore.org
IRB/Protocol Number   16-02-335Q-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Cardiology - Other Respiratory and Intrathoracic Organs